Omega Healthcare Investors, Inc. $OHI Shares Purchased by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Omega Healthcare Investors, Inc. by 18.8% during the 2nd quarter, holding approximately 352,465 shares valued at $12.9 million.
• A number of analysts, including those from Wells Fargo and Scotiabank, have raised their price targets for Omega Healthcare Investors, reflecting a consensus rating of "Moderate Buy”.
• The company announced a quarterly dividend of $0.67, leading to an annualized dividend yield of 6.5%, though it has a high payout ratio of 165.43%.

Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 18.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 352,465 shares of the real estate investment trust's stock after purchasing an additional 55,880 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 0.12% of Omega Healthcare Investors worth $12,925,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in OHI. AQR Capital Management LLC increased its stake in Omega Healthcare Investors by 430.8% during the first quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock worth $108,989,000 after acquiring an additional 2,322,878 shares during the last quarter. Vanguard Group Inc. raised its holdings in Omega Healthcare Investors by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after buying an additional 1,492,904 shares during the period. Invesco Ltd. lifted its position in Omega Healthcare Investors by 122.3% in the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock worth $92,023,000 after buying an additional 1,329,324 shares during the last quarter. Nuveen LLC purchased a new position in Omega Healthcare Investors during the first quarter worth $42,513,000. Finally, Allspring Global Investments Holdings LLC increased its position in Omega Healthcare Investors by 556.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock valued at $39,143,000 after acquiring an additional 871,472 shares during the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.50% of the company's stock.

Omega Healthcare Investors Stock Down 1.1%

NYSE:OHI traded down $0.47 during mid-day trading on Monday, hitting $41.06. 2,840,562 shares of the company's stock traded hands, compared to its average volume of 1,712,041. The company has a market capitalization of $12.11 billion, a P/E ratio of 25.35, a P/E/G ratio of 2.17 and a beta of 0.71. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The company has a fifty day moving average of $40.83 and a 200 day moving average of $38.45. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. Omega Healthcare Investors's revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.5%. Omega Healthcare Investors's payout ratio is 165.43%.

Analyst Ratings Changes

A number of research analysts have recently commented on OHI shares. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Scotiabank upped their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. Truist Financial raised their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research report on Wednesday, September 3rd. Mizuho boosted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday, September 11th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Omega Healthcare Investors presently has an average rating of "Moderate Buy" and an average price target of $43.75.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.